MX2013008729A - Metodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales. - Google Patents
Metodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales.Info
- Publication number
- MX2013008729A MX2013008729A MX2013008729A MX2013008729A MX2013008729A MX 2013008729 A MX2013008729 A MX 2013008729A MX 2013008729 A MX2013008729 A MX 2013008729A MX 2013008729 A MX2013008729 A MX 2013008729A MX 2013008729 A MX2013008729 A MX 2013008729A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- visual system
- treating
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Se divulgan métodos y composiciones para tratar, reducir o prevenir el deterioro de al menos un componente del sistema visual de un animal. Los métodos comprenden administrar al animal una composición que comprende AGI y CLON en una cantidad eficaz para tratar, reducir o prevenir el deterioro de al menos un componente del sistema visual. También se describen los métodos para prolongar los años de plenitud de la vida de un animal, mejorar la calidad de vida y fomentar la salud y el bienestar de un animal, utilizando composiciones que comprenden los AGI y CLON.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161461913P | 2011-01-25 | 2011-01-25 | |
PCT/US2012/022297 WO2012103049A1 (en) | 2011-01-25 | 2012-01-24 | Methods and compositions for treating, reducing or preventing deterioration of the visual system of animals |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013008729A true MX2013008729A (es) | 2013-08-14 |
MX348898B MX348898B (es) | 2017-07-03 |
Family
ID=46581129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013008729A MX348898B (es) | 2011-01-25 | 2012-01-24 | Métodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales. |
Country Status (12)
Country | Link |
---|---|
US (1) | US9320759B2 (es) |
EP (1) | EP2667882B1 (es) |
JP (1) | JP2014504605A (es) |
CN (1) | CN103442725A (es) |
AU (1) | AU2012209285B2 (es) |
BR (1) | BR112013018839A2 (es) |
CA (1) | CA2825022A1 (es) |
ES (1) | ES2828479T3 (es) |
MX (1) | MX348898B (es) |
RU (1) | RU2597793C2 (es) |
WO (1) | WO2012103049A1 (es) |
ZA (1) | ZA201306388B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2667640C1 (ru) | 2013-12-19 | 2018-09-21 | Тассос ГЕОРГИУ | Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы |
WO2015091410A1 (en) * | 2013-12-19 | 2015-06-25 | F. Hoffmann-La Roche Ag | Cetp modulator for use in the treatment of eye disease |
MX2017004662A (es) * | 2014-10-10 | 2017-07-26 | Nestec Sa | Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad. |
RU2632958C2 (ru) * | 2015-10-20 | 2017-10-11 | федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный технический университет им. И.И. Ползунова" (АлтГТУ) | Сироп бальзамный для профилактики потери остроты зрения |
WO2017109623A1 (en) * | 2015-12-22 | 2017-06-29 | Nestec Sa | Immune health for companion animals |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
CN106689960A (zh) * | 2017-01-11 | 2017-05-24 | 珠海市御得养生食品研究院有限公司 | 一种保护视力固体饮料 |
MA49906A (fr) | 2017-08-14 | 2020-06-24 | Axcella Health Inc | Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie |
JP2021527670A (ja) | 2018-06-20 | 2021-10-14 | アクセラ・ヘルス・インコーポレイテッドAxcella Health Inc. | 筋肉中の脂肪浸潤の治療のための組成物及び方法 |
US11696593B2 (en) | 2018-08-24 | 2023-07-11 | Bioscience Formulators, LLC | Astaxanthin nutritional compositions and uses |
US11503851B1 (en) * | 2021-06-28 | 2022-11-22 | DailyColors Health, Inc. | Compositions and methods to counteract processes associated with inflammation and senescence and to support cellular energy and/or metabolism |
WO2023183212A1 (en) * | 2022-03-22 | 2023-09-28 | Ark Naturals Company | Edible soft dental chew and methods of using the same |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5952033A (en) | 1996-12-24 | 1999-09-14 | Nestec S.A. | Gelatinized cereal product containing oligosaccharide and processes of preparing and using same |
PT862863E (pt) | 1997-01-09 | 2002-04-29 | Nestle Sa | Produto cerealifero contendo probioticos |
ATE397868T1 (de) | 1999-09-07 | 2008-07-15 | Nestle Sa | Verfahren zur verbesserung der haut und des pelzes von haustieren |
BR0007166A (pt) | 1999-09-22 | 2001-07-31 | Nestle Sa | Método para aumentar a atividade dos animais de estimação |
DE60119515T2 (de) | 2000-05-25 | 2007-05-24 | Société des Produits Nestlé S.A. | Probiotica für verwendung als haustierfutter |
DE60122523T2 (de) | 2000-05-26 | 2007-05-03 | Société des Produits Nestlé S.A. | Futter für haustiere |
GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
EP1344458A1 (en) | 2002-03-12 | 2003-09-17 | Société des Produits Nestlé S.A. | Probiotic delivery system |
US7887847B2 (en) | 2004-05-08 | 2011-02-15 | Paul Jr Edward L | Nutritional supplement for treatment of ocular diseases |
US20060046982A1 (en) | 2004-08-26 | 2006-03-02 | Waugh William H | Orthomolecular medical use of L-citrulline for capillary endothelial protection and adjacent cell protection in neurodegenerative disease |
US20060088574A1 (en) | 2004-10-25 | 2006-04-27 | Manning Paul B | Nutritional supplements |
WO2007022991A1 (en) | 2005-08-26 | 2007-03-01 | Nestec S.A. | Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain |
WO2007041418A2 (en) | 2005-09-30 | 2007-04-12 | Nestec S.A. | Methods and compositions for improving cognitive function |
WO2008143642A2 (en) | 2006-11-09 | 2008-11-27 | Children's Medical Center Corporation | Methods of treating and preventing ocular neovascularization with omega-3 polyunsaturated fatty acids |
AU2008307494B2 (en) * | 2007-10-04 | 2013-09-05 | Société des Produits Nestlé S.A. | Compositions and methods for enhancing cognitive function |
US20090110674A1 (en) * | 2007-10-24 | 2009-04-30 | Loizou Nicos C | Health supplement |
BRPI0820802A2 (pt) * | 2007-12-17 | 2015-06-16 | Univ Florida | Materiais e métodos para tratamento de proliferação vascular ocular patológica |
WO2009088433A1 (en) | 2008-01-04 | 2009-07-16 | Nestec S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions |
US20090325999A1 (en) * | 2008-06-27 | 2009-12-31 | Jie Du | Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions |
WO2010074940A1 (en) * | 2008-12-23 | 2010-07-01 | Alcon Research, Ltd. | Compositions and nutritional supplements for improving ocular health and reducing ocular inflammatory response |
JP5872453B2 (ja) * | 2009-04-17 | 2016-03-01 | ナタク ファルマ エセ.エレ. | フィタン酸含量が低く、ω−3脂肪酸に富む組成物 |
US20110208153A1 (en) * | 2010-02-24 | 2011-08-25 | John Alvey | Formulations and methods for nutrient delivery |
-
2012
- 2012-01-24 AU AU2012209285A patent/AU2012209285B2/en not_active Ceased
- 2012-01-24 MX MX2013008729A patent/MX348898B/es active IP Right Grant
- 2012-01-24 ES ES12739643T patent/ES2828479T3/es active Active
- 2012-01-24 CA CA2825022A patent/CA2825022A1/en not_active Abandoned
- 2012-01-24 CN CN2012800149119A patent/CN103442725A/zh active Pending
- 2012-01-24 BR BR112013018839A patent/BR112013018839A2/pt not_active Application Discontinuation
- 2012-01-24 EP EP12739643.0A patent/EP2667882B1/en active Active
- 2012-01-24 JP JP2013550661A patent/JP2014504605A/ja active Pending
- 2012-01-24 US US13/981,220 patent/US9320759B2/en active Active
- 2012-01-24 WO PCT/US2012/022297 patent/WO2012103049A1/en active Application Filing
- 2012-01-24 RU RU2013139430/15A patent/RU2597793C2/ru not_active IP Right Cessation
-
2013
- 2013-08-23 ZA ZA2013/06388A patent/ZA201306388B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2828479T3 (es) | 2021-05-26 |
US20130309329A1 (en) | 2013-11-21 |
BR112013018839A2 (pt) | 2016-09-27 |
EP2667882A1 (en) | 2013-12-04 |
MX348898B (es) | 2017-07-03 |
AU2012209285B2 (en) | 2016-11-17 |
AU2012209285A1 (en) | 2013-08-01 |
JP2014504605A (ja) | 2014-02-24 |
CA2825022A1 (en) | 2012-08-02 |
CN103442725A (zh) | 2013-12-11 |
RU2013139430A (ru) | 2015-03-10 |
WO2012103049A1 (en) | 2012-08-02 |
US9320759B2 (en) | 2016-04-26 |
RU2597793C2 (ru) | 2016-09-20 |
EP2667882A4 (en) | 2014-06-25 |
ZA201306388B (en) | 2015-03-25 |
EP2667882B1 (en) | 2020-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013008729A (es) | Metodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales. | |
WO2012112340A3 (en) | Methods and compositions for treating, reducing, or preventing damage to the nervous system of animals | |
MX2009011898A (es) | Composiciones y metodos para tratar trastornos asociados con retencion de sal o fluido. | |
GB201318761D0 (en) | Compounds for the treatment of neuropsychiatric disorders | |
PH12014502698B1 (en) | Improved antagonist antibodies against gdf-8 and uses therefor | |
MY153948A (en) | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof | |
MX351670B (es) | Bacteria bacillus para uso en tratar y prevenir infecciones en animales acuaticos. | |
MX2013007189A (es) | Metodos y composiciones adecuados para manejar glucosa en sangre en animales. | |
EP2294184A4 (en) | TREATMENT OF EYE DISEASES AND EXCESSIVE NEOVASCULARIZATION WITH THE HELP OF COMBINED THERAPY | |
MX337614B (es) | Tratamiento de lupus nefritis usando laquinimod. | |
MY150602A (en) | Subtituted-quinoxaline-type piperidine compounds and the uses thereof | |
NZ602478A (en) | Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate | |
WO2015157559A3 (en) | 10',11'-modified saxitoxins useful for the treatment of pain | |
MX363465B (es) | Tratamiento de la grasa submental. | |
NZ597031A (en) | Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm) | |
AU2016216741A1 (en) | Compositions and methods of use of an inappetance-controlling compound | |
DK2714888T3 (da) | Rekombinant gær | |
EP2490700A4 (en) | EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF | |
EA201200428A1 (ru) | Композиция и способ для лечения ожирения | |
MX2011012310A (es) | Tratamiento de insuficiencia cardiaca con fracción de eyeccion normal (icfen). | |
MX347263B (es) | Metodos para incrementar la produccion o actividad de catalasa. | |
WO2011153377A3 (en) | Methods and compositions for treating a subject for central nervous system (cns) injury | |
ATE538799T1 (de) | Zusammensetzungen zur behandlung von haarverlust | |
MX2011007885A (es) | Formulaciones de emulsion de narcoticos para tratamiento de dolor por cancer. | |
WO2014026013A3 (en) | Methods for maintaining or improving health, well-being and/or a physiological function in a subject |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |